Clinical trial
Efficacy of Supplemental Protein, Delivered Alone or in Combination With Treatment for Enteric Pathogens, to Prevent Growth Faltering in Bangladeshi Infants
NCT03683667 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Supplemental Protein, Delivered Alone or in Combination With Treatment for Enteric Pathogens, to Prevent Growth Faltering in Bangladeshi Infants
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 23, 2018
- Completion date
- March 24, 2020
- Enrollment
- 5,283 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
campylobacter infections, enteric pathogens, malnutrition; protein, stunting